Ulisse Biomed
UBM | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0005451213 (+1 more)
- LEI:
- 815600F9C180B297BE35
- Country:
- Italy
- Address:
- VIA AQUILEIA, 17, 33100 UDINE
- Website:
- https://www.ulissebiomed.com/en
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Ulisse BioMed is an Italian healthcare biotech company Founded in 2015, Ulisse BioMed is an Italian healthcare biotech company with corporate offices in Udine, Italy and with R&D and Manufacturing labs in Trieste, Italy. Ulisse BioMed is creating novel, innovative and transformative diagnostic platforms and products. The Company mission and purpose for the science, technologies and products is to create new diagnostic modalities and care models in settings never thought possible throughout the world.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-30 12:21 |
Share Issue/Capital Change
APERTURA DEL SETTIMO PERIODO DI ESERCIZIO DEI “WARRANT ULISSE BIOMED S.P.A. 202…
|
Italian | 188.9 KB | |
| 2025-05-12 12:02 |
Regulatory News Service
WEBSIM INIZIA LA COPERTURA DEL TITOLO UBM
|
Italian | 181.7 KB | |
| 2025-04-28 16:36 |
General Meeting Notice
RINVIO ASSEMBLEA ORDINARIA E STRAORDINARIA IN SECONDA CONVOCAZIONE
|
Italian | 181.0 KB | |
| 2025-04-12 14:07 |
General Meeting Notice
CONVOCAZIONE DELL’ASSEMBLEA ORDINARIA E STRAORDINARIA DEGLI AZIONISTI E DEPOSIT…
|
Italian | 203.8 KB | |
| 2025-03-28 21:22 |
Annual Report
IL CONSIGLIO DI AMMINISTRAZIONE DI ULISSE BIOMED APPROVA IL PROGETTO DI BILANCI…
|
Italian | 488.4 KB | |
| 2025-03-12 06:50 |
Regulatory News Service
AVVIO DELLA SECONDA FASE DEL PROGETTO DI SVILUPPO PER LA LOTTA CONTRO LA MALARIA
|
Italian | 185.7 KB | |
| 2025-02-14 17:43 |
Foreign Filer Report
COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
|
Italian | 250.9 KB | |
| 2025-01-29 17:52 |
General Meeting Notice
CALENDARIO EVENTI SOCIETARI 2025
|
Italian | 189.2 KB | |
| 2024-12-30 18:28 |
Major Shareholding Notification
COMUNICAZIONE CAMBIAMENTO SOSTANZIALE DEGLI AZIONISTI RILEVANTI (ART.17 REGOLAM…
|
Italian | 229.0 KB | |
| 2024-12-30 18:10 |
Major Shareholding Notification
INTERAMENTE SOTTOSCRITTO L’AUMENTO DI CAPITALE SOCIALE PER UN AMMONTARE COMPLES…
|
Italian | 210.4 KB | |
| 2024-12-27 20:59 |
Interim Report
IL CONSIGLIO DI AMMINISTRAZIONE ESERCITA LA DELEGA AD AUMENTARE IL CAPITALE SOC…
|
Italian | 274.6 KB | |
| 2024-12-20 16:33 |
Regulatory News Service
COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
|
Italian | 262.3 KB | |
| 2024-12-17 18:36 |
General Meeting Notice
ASSEMBLEA ORDINARIA E STRAORDINARIA
|
Italian | 222.3 KB | |
| 2024-12-16 18:10 |
General Meeting Notice
RINVIO ASSEMBLEA ORDINARIA E STRAORDINARIA IN SECONDA CONVOCAZIONE
|
Italian | 188.8 KB | |
| 2024-12-11 19:41 |
Regulatory News Service
IL CONSIGLIO DI AMMINISTRAZIONE HA ESAMINATO I DATI PRELIMINARI DI CHIUSURA DEL…
|
Italian | 324.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |